跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
allogeneic stem cell therapy
首页
药物
allogeneic stem cell therapy
allogeneic stem cell therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US 8147824 B2
申请人: MAZIARZ RICHARD
优先权: 2005
EP
US
9 件公开
CD5 specific T cell receptor cell or gene therapy
US 12479903 B2
申请人: MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT
优先权: 2019
EP
US
WO
5 件公开
METHODS AND COMPOSITIONS FOR THE EXPANSION AND USE OF ALLOGENEIC GAMMA/DELTA-T CELLS
EP 3856206 C0
申请人: PHOSPHOGAM INC
优先权: 2018
CN
EP
US
WO
4 件公开
COMPOSITIONS AND METHODS FOR ALLOGENEIC TRANSPLANTATION
EP 4107188 A4
申请人: MAGENTA THERAPEUTICS INC
优先权: 2020
CN
EP
US
WO
4 件公开
ALLOGENEIC STEM CELL BANK
US 2008227197 A1
申请人: STEMCYTE INC
优先权: 2003
US
4 件公开
Rapamycin-resistant T cells and therapeutic uses thereof
US 7718196 B2
申请人: US GOV HEALTH & HUMAN SERV
优先权: 2005
US
4 件公开
Methods and Compositions for Infusion of Transiently Engrafting, Selected Populations of Allogeneic Lymphocytes to Treat Cancer
US 2015132290 A1
申请人: UNIV JOHNS HOPKINS
优先权: 2013
US
4 件公开
IMMUNE COMPATIBLE CELLS FOR ALLOGENEIC CELL THERAPIES TO COVER GLOBAL, ETHNIC, OR DISEASE-SPECIFIC POPULATIONS
EP 4599046 A1
申请人: GARUDA THERAPEUTICS INC
优先权: 2022
EP
US
WO
3 件公开
US 20250332260 A1
申请人: GARUDA THERAPEUTICS INC
优先权: 2024
US
WO
2 件公开
OPTIMIZED METHODS FOR GENERATION OF CARDIAC STEM CELLS FROM CARDIAC TISSUE AND THEIR USE IN CARDIAC THERAPY
US 2015216905 A1
申请人: CAPRICOR INC
优先权: 2013
US
3 件公开
METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
US 2021379195 A1
申请人: MAGENTA THERAPEUTICS INC
优先权: 2018
CN
US
2 件公开
第 1 / 4 页
上一页
下一页
药物
反馈